Skip to main content

Table 3 Toxicity profile

From: Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy

 

Acute toxicity

Late toxicity

 

Grade

Nb. patients (%)

Grade

Nb. patients (%)

Mucosal Toxicity

0

15 (15 %)

0

99 (97 %)

 

1

33 (32 %)

1

2 (2 %)

 

2

43 (42 %)

2

1 (1 %)

 

3

11 (11 %)

3

-

Salivary Toxicity

0

74 (73 %)

0

64 (63 %)

 

1

24 (23 %)

1

19 (19 %)

 

2

4 (4 %)

2

18 (18 %)

 

3

-

3

1 (1 %)

Taste Toxicity

0

65 (64 %)

0

82 (80 %)

 

1

29 (28 %)

1

13 (13 %)

 

2

8 (8 %)

2

7 (7 %)

Swallowing Toxicity

0

49 (48 %)

0

99 (97 %)

 

1

21 (20 %)

1

2 (2 %)

 

2

26 (25 %)

2

1 (1 %)

 

3

6 (6 %)

3

-

Skin Toxicity

0

26 (25 %)

0

102 (100 %)

 

1

39 (38 %)

1

-

 

2

33 (31 %)

2

-

 

3

4 (4 %)

3

-